Argenx
ARGX
#422
Rank
C$77.66 B
Marketcap
C$1,247
Share price
-1.62%
Change (1 day)
41.46%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

P/S ratio for Argenx (ARGX)

P/S ratio as of December 2025 (TTM): 15.5

According to Argenx 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.18. At the end of 2025 the company had a P/S ratio of 12.5.

P/S ratio history for Argenx from 2022 to 2021

PS ratio at the end of each year

Year P/S ratio Change
202512.5-26.97%
202417.1-7.08%
202318.4-63.94%
202251.0-17.8%
202162.1
201978.6-34.76%
2018120201.52%
201739.9
201425.2